← Leaderboards
Siddhesh Angle
Regenosine Inc
$2,469,582
Attributed
$2,469,582
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $860.4K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,469,582 · 2
By mechanism
R44$1,671,789 · 1
SB1$797,793 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Deterioration”
- Barbara Halina Braffett · George Washington University$7,285,878
- Patricia Pavlinac · University Of Washington$6,692,400
- Sook-Lei Liew · University Of Southern California$6,121,666
- Kei M Igarashi · University Of California-Irvine$5,826,395
- Patricio Sepulveda · Amplo Biotechnology, Inc.$5,506,739
- Francesca E. Duncan · Northwestern University At Chicago$5,269,165
Research focus
DeteriorationFirst-In-HumanChondrocytesDegenerative PolyarthritisDoseExtracellularCanis FamiliarisCartilage RegenerationClinical TrialsCostDifferential ExpressionAdenosineAgingDrug KineticsAgonistArthropathiesCartilageBiologicalAffectBiomechanicsConsumptionBone SpurAftercareFormulation
Grant awards (4)
Treatment and prevention of osteoarthritis with an intra-articular disease-modifying regenerative therapy$399,378
SB1 · FY2025 · AR · contact PI
Treatment and prevention of osteoarthritis with an intra-articular disease-modifying regenerative therapy$398,415
SB1 · FY2024 · AR · contact PI
Treatment and prevention of osteoarthritis with an intra-articular disease-modifying regenerative therapy$811,405
R44 · FY2022 · AR · contact PI
Treatment and prevention of osteoarthritis with an intra-articular disease-modifying regenerative therapy$860,384
R44 · FY2021 · AR · contact PI